Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Why adherence is a sensitive issue

by Nicola Gray and Gianpiero Celino

Nicola Gray and Gianpiero Celino look at how pharmacists can help patients struggling with adherence to their medication


Partial adherence to drug regimen

Between one-third and one half of medicines prescribed for long-term conditions are not taken as intended. The consequences of this range from the inconvenient (eg, moderate pain) to the life-threatening (eg, graft rejection).

It is an extraordinary challenge to improve clinical outcomes and reduce this medicines wastage, but it is also an opportunity for pharmacists.

Although it is true that some prescriptions will not reach the pharmacy, the point of dispensing is a chance to make a difference.

Citation: The Pharmaceutical Journal URI: 10026101

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.


Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Partial adherence to drug regimen

Supplementary information

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.